Prognostic, Immunological, and Mutational Analysis of MTA2 in Pan-Cancer and Drug Screening for Hepatocellular Carcinoma.

Xueshan Huang,Jingyi Tan,Mei Chen,Weirang Zheng, Shanyang Zou,Xiaoxia Ye, Yutong Li,Minhua Wu

Biomolecules（2023）

引用 0|浏览3

暂无评分

摘要

Our study demonstrated that MTA2 plays crucial roles in tumor progression and tumor immunity, and it could be used as a prognostic marker for various malignancies. MK-886 might be a powerful drug for HCC.

查看译文

关键词

hepatocellular carcinoma,mta2,drug screening,pan-cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要